99021849 - CRENESSITY

Information

• Trademark
• 99021849

• Source

• Serial Number

  99021849

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  January 29, 2025
  9 days ago

• Transaction Date

  January 29, 2025
  9 days ago

• Status Date

  January 29, 2025
  9 days ago

• Status Code

  630

• Attorney Docket Number

  NEUB 2504289

  Attorney Name

  Allison Strickland Ricketts

• Owners

  • Neurocrine Biosciences, Inc.

Case File Statements

• DM0000: The mark consists of four lines with curved top and bottom edges that become progressively larger from left to right and form the overall shape of a conical seashell, positioned above the word CRENESSITY.
• GS0051: Pharmaceutical preparations for the treatment of adrenal insufficiency; pharmaceutical preparations for the treatment of hormonal and genetic diseases, disorders and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia; pharmaceuticals for the treatment of rare and orphan hormonal and genetic diseases, disorders and conditions
• GS0441: Providing medical information; Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders
• GS0421: Providing medical research information; providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders, for others; conducting post-authorization pharmaceutical research for the marketing of pharmaceutical preparations and evaluating epidemiological results

Case File Event Statements

• 1/29/2025 - 9 days ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/29/2025 - 9 days ago

  2 - APPLICATION FILING RECEIPT MAILED Type: MAFR